Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (21-30 of 2,959) with videos related to

Pageof 296
Sort By:
Hospital Practice (Office Ed.)|March 15, 1995
Deep vein thrombosis: recovery or recurrence?J Hirsh
The Pharmacogenomics Journal|March 26, 2002
Time flies like an arrow. Fruit flies like crack?J Hirsh
Haemostasis|January 1, 1986
In vivo effects of low molecular weight heparins on experimental thrombosis and bleedingJ Hirsh
Expert Review of Anticancer Therapy|January 29, 2014
nab-paclitaxel for the management of patients with advanced non-small-cell lung cancerVera Hirsh
Archives of Internal Medicine|October 1, 1991
Influence of low-intensity warfarin treatment on patients' perceptions of quality of lifeJ Hirsh
Seminars in Thrombosis and Hemostasis|January 1, 1986
Mechanism of action and monitoring of anticoagulantsJ Hirsh
Archives of Internal Medicine|April 1, 1987
Is the dose of warfarin prescribed by American physicians unnecessarily high?J Hirsh
Annals of the New York Academy of Sciences|January 1, 1989
Heparin therapy in venous thromboembolismJ Hirsh
Thrombosis and Haemostasis|October 11, 2014
Solving the mystery of excessive warfarin-induced bleeding: a personal historical perspectiveJack Hirsh
World Journal of Clinical Oncology|June 14, 2014
Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?Vera Hirsh
Pageof 296

Showing results (21-30 of 2,959) with videos related to

Sort By:
Pageof 296
Hospital Practice (Office Ed.)|March 15, 1995
Deep vein thrombosis: recovery or recurrence?J Hirsh
The Pharmacogenomics Journal|March 26, 2002
Time flies like an arrow. Fruit flies like crack?J Hirsh
Haemostasis|January 1, 1986
In vivo effects of low molecular weight heparins on experimental thrombosis and bleedingJ Hirsh
Expert Review of Anticancer Therapy|January 29, 2014
nab-paclitaxel for the management of patients with advanced non-small-cell lung cancerVera Hirsh
Archives of Internal Medicine|October 1, 1991
Influence of low-intensity warfarin treatment on patients' perceptions of quality of lifeJ Hirsh
Seminars in Thrombosis and Hemostasis|January 1, 1986
Mechanism of action and monitoring of anticoagulantsJ Hirsh
Archives of Internal Medicine|April 1, 1987
Is the dose of warfarin prescribed by American physicians unnecessarily high?J Hirsh
Annals of the New York Academy of Sciences|January 1, 1989
Heparin therapy in venous thromboembolismJ Hirsh
Thrombosis and Haemostasis|October 11, 2014
Solving the mystery of excessive warfarin-induced bleeding: a personal historical perspectiveJack Hirsh
World Journal of Clinical Oncology|June 14, 2014
Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?Vera Hirsh
Pageof 296